Search Results
Apr 02, 2026, 09:00 ET ZEISS advances connected cataract and refractive workflows with new digital, AI and surgical innovations at ASCRS
www.zeiss.com/med.
More news about: Carl Zeiss Meditec AG
Apr 02, 2026, 09:00 ET ZEISS advances connected cataract and refractive workflows with new digital, AI and surgical innovations at ASCRS
www.zeiss.com/med.
More news about: Carl Zeiss Meditec AG
Apr 01, 2026, 10:00 ET PranaX Corporation Appoints Dr. Richard H. LeConey, MD as Chief Medical Officer
wellness therapies," said Dr. Steven J. Greco, PhD, COO of PranaX. "As we continue to expand our clinical footprint and strengthen partnerships across the med spa and physician community, his leadership will be instrumental in advancing our strategy and supporting the responsible adoption of our products."Dr.
More news about: PranaX
Apr 01, 2026, 07:07 ET Fosun International Holds 2025 Annual Results Presentation: Fosun has the Ability to Navigate Through Cycles
companies, Fosun United Health Insurance and Pramerica Fosun Life Insurance, recorded significant profit increases. In the culture and tourism business, Club Med achieved record-high results."These businesses are capable of generating sustainable profit and cash flow, laying the foundation for Fosun's continued
More news about: Fosun
Apr 01, 2026, 00:45 ET SirPAD: Os resultados primários confirmam a segurança e a eficácia do balão revestido com sirolimus no PAD
estatístico suficientes para demonstrar superioridade para resultados clínicos difíceis em um ano ", disse o Prof. Dr. med, dos Investigadores Principais. Nils Kucher e Prof. Dr. med. Stefano Barco, copresidentes deste julgamento inovador após a apresentação.O SirPAD é um estudo de mudança
More news about: Concept Medical
Apr 01, 2026, 00:38 ET SirPAD: los resultados primarios confirman la seguridad y eficacia del balón recubierto con sirolimus en PAD
poder estadístico para demostrar la superioridad de los resultados clínicos duros en un año ", dijeron los investigadores principales, el Prof. Dr. med. Nils Kucher y Prof. Dr. en medicina, Stefano Barco, copresidentes de este innovador ensayo tras la presentación.SirPAD es un ensayo
More news about: Concept Medical
Mar 31, 2026, 22:59 ET SirPAD: Los resultados primarios confirman la seguridad y eficacia del balón recubierto de sirolimus en PAD
para demostrar la superioridad en los resultados clínicos importantes al año", dijeron los investigadores principales Prof. Dr. med. Nils Kucher y Prof. Dr. med. Stefano Barco, copresidentes de este innovador ensayo tras la presentación.SirPAD es un ensayo revolucionario cuyos datos
More news about: Concept Medical
Mar 31, 2026, 14:37 ET /C O R R E C T I O N -- DERMAFLASH/
FEATURESAward-Winning Sonic Technology Friction-free glide and proven skin health benefits For med spas, day spas and dermatology clinicsCustom-engineered MicroSonic Edge™ Maximum precision and maneuverabilityUltimate
More news about: DERMAFLASH
Mar 31, 2026, 11:15 ET DeuteRx Celebrates Women's History Month with Over a Decade of Pioneering Leadership in Drug Discovery
ACS Med Chem 2020, 11, 1789). She cofounded Deuteria Pharmaceuticals to lead the initial proof-of-concept of DECS: the discovery of deuterium-stabilized
More news about: DeuteRx LLC
Mar 31, 2026, 09:02 ET New study demonstrates feasibility and safety of deprescribing diabetes medications when lifestyle medicine is integrated into primary care
paper stated. "These findings add to a growing understanding of how deprescribing can be approached in primary care," said Gia Merlo, MD, MBA, MEd, DipABLM, FACLM, professor, Department of Psychiatry at NYU Grossman School of Medicine. "They suggest that when lifestyle medicine is incorporated into
More news about: American College of Lifestyle Medicine
Mar 31, 2026, 07:46 ET Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year
2016;22 (Suppl 3):1–203.Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide 25 mg in adults with overweight or obesity. N Engl J Med. 2025; 393:1077-1087. DOI: 10.1056/NEJMoa2500969.Centers for Disease Control and Prevention. Risk Factors for Obesity. Last accessed: December
More news about: Novo Nordisk
Mar 31, 2026, 06:01 ET Fosun International: Gesamtumsatz 2025 erreicht 173,43 Mrd. RMB, Auslandserlöse machen 54,7 % aus, Ziel: „10 Mrd. RMB Gewinn"
Gesamtzahlungen aus Lizenzvergaben und Co-Entwicklung im Jahr 260 Mio. USD, während die potenziellen Meilensteinzahlungen insgesamt über 4 Mrd. USD lagen. Club Med erzielte erneut eine Rekordleistung, während die Versicherungsgesellschaften in China und im Ausland ein breites Wachstum zeigten.Fosun hat seine
More news about: Fosun
Mar 31, 2026, 05:52 ET Fosun International : le chiffre d'affaires total en 2025 atteint 173,43 milliards de RMB, les revenus à l'international représentant 54,7 %, avec l'objectif d'atteindre « 10 milliards de RMB de bénéfices »
totaux excédant 4 milliards USD.Club Med, filiale de Fosun Tourism Group, dispose d'opérations de vente et de marketing dans plus de 40 pays et régions sur six continents, et exploite 67 villages de vacances. Au cours de la période de référence, Club Med a de nouveau réalisé une performance record,
More news about: Fosun
Mar 31, 2026, 05:35 ET Guo Guangchang: Fosun International's NAV reaches HKD18.1 Per Share, Focusing Resources on Core, High‑Growth Areas
companies, Fosun United Health Insurance and Pramerica Fosun Life Insurance, recorded significant profit increases. In the culture and tourism business, Club Med achieved record-high results."These businesses are capable of generating sustainable profit and cash flow, laying the foundation for Fosun's continued
More news about: Fosun
Mar 31, 2026, 05:00 ET Resilience Care Expands to U.S. Market, Adds Veteran Digital Health Leaders to Support Growth with Oncology Providers
by Resilience Care among healthcare professionals in Europe.[4] Basch, JCO 2016 ; Basch et al, JAMA 2022 ; Mir et al, Nat Med 2022 ; Patt, JCO Clin Informatics 2023.[5] Basch, JCO 2016.Logo:
More news about: Resilience Care
Mar 31, 2026, 03:56 ET SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD
and statistical power to demonstrate superiority for hard clinical outcomes at one year," said Principal Investigators Prof. Dr. med. Nils Kucher and Prof. Dr. med. Stefano Barco, co-chairs of this groundbreaking trial after the presentation.SirPAD is a gamechanger trial with the data
More news about: Concept Medical
Mar 31, 2026, 03:51 ET SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD
and statistical power to demonstrate superiority for hard clinical outcomes at one year," said Principal Investigators Prof. Dr. med. Nils Kucher and Prof. Dr. med. Stefano Barco, co-chairs of this groundbreaking trial after the presentation.SirPAD is a gamechanger trial with the data
More news about: Concept Medical
Mar 30, 2026, 13:37 ET KFC® Has an Answer to the Value Wars: A Value Feast Fit for the Moment
HI, CA and third-party ordering websites. Tax, tip and fees extra. **Box Feasts include 3 oz. fries and med. drink. ***At participating locations only.About KFC KFC Corporation, based in Plano, TX., has
More news about: Kentucky Fried Chicken
Mar 30, 2026, 11:26 ET Fosun International: Total Revenue in 2025 Reaches RMB173.43 Billion, with Overseas Revenue Accounting for 54.7%, Aiming to Achieve"RMB10 Billion in Profit"
payments from licensing-out and co-development for the year exceeded USD260 million, with total potential milestone payments exceeding USD4 billion. Club Med once again achieved record-high performance, while insurance companies in China and overseas delivered broad-based growth.Fosun has continued
More news about: Fosun
Mar 30, 2026, 11:13 ET Guo Guangchang's Letter to Shareholders: "Repair the Roof While the Sun Is Shining" -- Fosun Aims to Go Further with Greater Stability
brand, Laomiao, opened its first overseas store in Kuala Lumpur, Malaysia. FTG, with Club Med as its core, has firmly strengthened lean management. During the core six-day Chinese New Year holiday period, Club Med's five all-inclusive resorts
More news about: Fosun
Mar 28, 2026, 15:15 ET Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
2026;doi:10.1002/art.70134.5 Mease PJ, et al. Arthritis Rheum. 2005;52(10):3279-3289.6 Mease PJ, et al. N Engl J Med. 2015;373(14):1329-1339.7 Mease PJ, et al. Ann Rheum Dis. 2017;76(1):79-87.8 Deodhar A, et al. Lancet.
More news about: Eli Lilly and Company
Mar 28, 2026, 14:39 ET Das Critical Path Institute startet die Initiative „One to Millions", um die Zukunft der personalisierten Medizin weltweit neu zu gestalten
beschreiben, wie entscheidend dieser Moment für die Veränderung von Leben und die lang erwartete Verwirklichung einer innovativen Vision ist", sagte Dr. med. Klaus Romero, MS, FCP, Chief Executive Officer des Critical Path Institute. „One to Millions wurde ins Leben gerufen, um personalisierte Therapien für
More news about: Critical Path Institute
Mar 27, 2026, 09:00 ET UCB Presents New BIMZELX® (bimekizumab-bkzx) Data at AAD Demonstrating High Rates of Durable and Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis
Lancet. 2021;397(10273):487–98.4. Reich K, Warren RB, Lebwohl M, et al. Bimekizumab versus Secukinumab in Plaque Psoriasis. N Engl J Med. 2021;385(2):142–52.5. Armstrong AW, Schupp C, Wu J, et al. Quality of Life and Work Productivity Impairment among Psoriasis Patients:
More news about: UCB
Mar 27, 2026, 09:00 ET UCB Announces New BIMZELX® (bimekizumab-bkzx) Data at AAD Showing Durable Symptom Control Throughout Three Years in Hidradenitis Suppurativa
hidradenitis suppurativa treatment. Br J Dermatol. 2014;171(6):1434–42.Jemec GBE. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158–64.Kimball AB, Jemec GBE, Sayed CJ, et al. Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis
More news about: UCB
Mar 26, 2026, 19:52 ET FDA approves Novo Nordisk's Awiqli®, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
https://doi.org/10.2337/dc26-S005Rosenstock J, Gowda A, Liang B. Weekly icodec versus daily glargine U100 in type 2 diabetes without previous insulin. N Engl J Med. 2023 2023;389(16):1533. doi:10.1056/NEJMc2310221Philis-Tsimikas A, Asong M, Franek E, et al. Switching to once-weekly insulin icodec versus
More news about: Novo Nordisk